VIM and breast carcinoma: The expression of vimentin may be mediated by β-catenin in TERT-siSFRP1 cells since β-catenin can transactivate vimentin in breast cancer cells [46] and β-catenin activity is enhanced in TERT-siFRP1 cells [16].